70 completed, 11 unknown, 6 active not recruiting, 6 recruiting. 34 Phase 2, 17 Phase 3, 16 Phase 1, 7 Not applicable, 1 Phase 4.
Follow Dengue Fever: new trials by email Literature Review of Dengue Fever trials Research Report on Dengue Fever
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Smart Analysis and Decision-Making for Emerging Infectious Diseases Multi-Agent Integrated Smart Toolkit for Emerging Infectious Diseases, Routine Practices - Emerging Infectious Diseases, COVID-19 | Not applicable | Enrolling by invitation | Peking University | 108 | 2026-08-10 | 2026-08-19 |
| Clinical Trial Evaluating Safety and Efficacy of Resomelagon on Dengue Infection (RESOVIR-2) Resomelagon, Placebo, Standard Treatment - Dengue Fever | Phase 2 | Recruiting | Federal University of Minas Gerais | 120 | 2026-03-20 | 2026-09-15 |
| Bridging Economics and Public Trust: A Study of Dengue Vaccine Cost-effectiveness and Acceptance in Thais Visiting Hospital Objective 1- economic evaluation of Thai children with dengue vaccine - Dengue Fever | Active not recruiting | Mahidol University | 350 | 2026-02-02 | 2026-08-17 | |
| A Study of Dengue Tetravalent Vaccine (TDV) in Adults (Age 45 to 60 and >60 to 79 Years) TDV, Placebo - Dengue Fever | Phase 3 | Active not recruiting | Takeda | 800 | 2026-01-20 | 2026-09-22 |
| International Registry of Dengue Infection in Congenital Bleeding Disorders (DengueCBDR) Dengue Disease, Dengue Haemorrhagic Fever | Recruiting | Mahidol University | 100 | 2025-12-01 | 2026-02-17 | |
| A Study on a New Tetravalent Dengue Vaccine (TDV) Formulation in Healthy Adults Tetravalent Dengue Vaccine (TDV) - Dengue Fever | Phase 3 | Active not recruiting | Takeda | 496 | 2025-11-07 | 2026-07-17 |
| To Assess the Efficacy of Carica Papaya Leaf Extract in Improving Platelet Counts Among Pediatric Patients With Dengue-associated Thrombocytopenia Carica Papaya Leaf Extract Group, standard treatment - Dengue Fever, Papaya Leaf Extract | Phase 2 | Enrolling by invitation | Ziauddin Hospital | 100 | 2025-10-01 | 2025-09-15 |
| Prospective Clinical Registry for Evaluation of Exanthematous Infections and Coinfections Exanthema, Dengue Fever | Not yet recruiting | Hospital Israelita Albert Einstein | 830 | 2025-09-01 | 2025-08-08 | |
| Xpert® Tropical Fever Test on GeneXpert® Edge X System Xpert Tropical Fever test - Malaria Fever, Zika | Enrolling by invitation | Cepheid | 2500 | 2025-08-18 | 2026-04-09 | |
| Risk Factors for Hospitalization and Transfusion Criteria in Patients With Dengue Virus Infection Dengue, Dengue Fever | Recruiting | Jose Ivan Rodriguez de Molina Serrano | 100 | 2025-08-01 | 2025-09-16 | |
| A Study of 2 Doses of Tetravalent Dengue Vaccine (TDV) in Infants and Toddlers TDV, Placebo - Dengue Fever | Phase 3 | Recruiting | Takeda | 212 | 2025-06-16 | 2026-06-29 |
| A Study in Children and Teenagers to Learn if a TDV Dengue Vaccination Lowers the Chance of Hospital Stays for Dengue No Intervention - Dengue Fever | Recruiting | Takeda | 70000 | 2025-03-05 | 2026-04-16 | |
| A Study of Dengue Tetravalent Vaccine (TDV) in Healthy Participants in Japan TDV, Placebo - Dengue Fever | Phase 2 / Phase 3 | Completed | Takeda | 187 | 2025-01-31 | 2025-12-30 |
| The Comparative Efficacy of Standard Treatment Plus Ribavirin vs Standard Treatment Alone in Preventing Clinically Significant Hemorrhage in Patients With Dengue Fever Ribavirin, Standard Treatment - Dengue Fever, Dengue Hemorrhagic Fever | Phase 3 | Completed | Khyber Medical University Peshawar | 284 | 2024-12-17 | 2025-06-26 |
| Prediction of Infectious Diseases in LMICs Using Electronic Health Record Data No intervention - Dengue Fever, Electronic Health Records | Completed | Mahidol University | 1000 | 2024-11-14 | 2026-02-25 | |
| A Study to Monitor the Adverse Events of QDENGA Vaccine in Participants in Malaysia No Intervention - Dengue Fever | Active not recruiting | Takeda | 2000 | 2024-09-26 | 2026-05-22 | |
| Characteristics of Clinical Laboratory Indicators in Patients with Dengue Fever Observational studies did not involve any interventions - Dengue Fever | Completed | Foshan Hospital of Traditional Chinese Medicine | 500 | 2024-08-01 | 2025-03-14 | |
| Abdominal Sonographic Findings and Their Association With Thrombocytopenia in Dengue Fever: A Cross-Sectional Study From an Endemic Region Dengue Fever | Completed | National Center for Gastroentestinal and Liver Disease | 150 | 2024-07-01 | 2026-06-02 | |
| Effects of Carica Papaya Leaf Extract (CPLE) in the Outcome of Hospitalized Dengue Patients CPLE, Placebo - Dengue Fever | Phase 1 / Phase 2 | Completed | Bangabandhu Sheikh Mujib Medical University, Dhaka, Bangladesh | 184 | 2024-06-01 | 2025-04-25 |
| Efficacy of Fresh Frozen Plasma (FFP) in Treating Thrombocytopenia in Dengue Patients Fresh frozen plasma - Dengue Fever, Dengue Hemorrhagic Fever | Not applicable | Active not recruiting | Sheikh Hasina National Institute of Burn and Plastic Surgery | 300 | 2024-05-01 | 2024-10-15 |
Showing 20 of 102. Sign in to see all of them.
Dengue (102) · Severe Dengue (38) · Chikungunya Fever (8) · Zika Virus Infection (5) · Hemorrhagic Fevers, Viral (3) · Malaria (3) · Fever (2) · Hemorrhage (2) · Thrombocytopenia (2) · Vector Borne Diseases (2) · Virus Diseases (2) · Yellow Fever (2) · Acquired Immunodeficiency Syndrome (1) · COVID-19 (1) · Chronic Disease (1)
Arbovirus Infections (102) · Flaviviridae Infections (102) · Flavivirus Infections (102) · Mosquito-Borne Diseases (102) · RNA Virus Infections (102) · Infections (101) · Vector Borne Diseases (100) · Virus Diseases (100) · Hemorrhagic Fevers, Viral (99) · Alphavirus Infections (8) · Pathological Conditions, Signs and Symptoms (8) · Togaviridae Infections (8) · Pathologic Processes (6) · Parasitic Diseases (3) · Protozoan Infections (3)
Dengue Vaccines (10) · Sodium Chloride (5) · Vaccines (4) · Aluminum Hydroxide (3) · Blood Specimen Collection (3) · ChimeriVax (2) · Dosage Forms (2) · Ribavirin (2) · Solutions (2) · adacel (2) · celgosivir (2) · 23-valent pneumococcal capsular polysaccharide vaccine (1) · AT-752 (1) · Biological Products (1) · Case-Control Studies (1)
Sanofi Pasteur, a Sanofi Company (24) · Takeda (15) · National Institute of Allergy and Infectious Diseases (NIAID) (8) · Sanofi (6) · U.S. Army Medical Research and Development Command (6) · Mahidol University (4) · Bangabandhu Sheikh Mujib Medical University, Dhaka, Bangladesh (2) · Clinical Research Centre, Malaysia (2) · Guangzhou 8th People's Hospital (2) · Kaohsiung Medical University Chung-Ho Memorial Hospital (2) · Singapore General Hospital (2) · Agence Sanitaire et Sociale de Nouvelle Calédonie (1) · Atea Pharmaceuticals, Inc. (1) · Centre Hospitalier Universitaire de la Réunion (1) · Centre Hospitalier de Cayenne (1)
United States (20) · Thailand (15) · Malaysia (11) · Colombia (10) · Brazil (9) · Mexico (8) · Singapore (8) · Philippines (7) · Puerto Rico (6) · Vietnam (6) · Indonesia (5) · Bangladesh (4) · China (4) · India (4) · Australia (3)
Anna Durbin, MD (5) · Aileen Chang, MD (1) · Akhtar Sherin, MBBS,MHR,PHD (1) · Alberto Santiago-Cornier, MD (1) · Anna Quintero, MD (1) · Ashley L St John (1) · Ashraful Hoque, DBST (1) · Beth-Ann Coller, PhD (1) · Cameron Simmons, PhD (1) · Christina Yek, M.D. (1)
PMID 40099800, PMID 26214039, PMID 29897841, PMID 33822015, PMID 26383952, PMID 27007959, PMID 27418050, PMID 27459266, PMID 28871961, PMID 29300876, PMID 33212068, PMID 34003796, PMID 34219653, PMID 35659904, PMID 42480195, PMID 15272410, PMID 15577938, PMID 16603571, PMID 18337339, PMID 19292665, PMID 19822889, PMID 21976579, PMID 22863660, PMID 22894958, PMID 22975340, PMID 23540847, PMID 23563266, PMID 23839107, PMID 23936565, PMID 24021313, PMID 24067553, PMID 24135573, PMID 24877997, PMID 25018116, PMID 25087476, PMID 25230594, PMID 25299251, PMID 25365753, PMID 25483647, PMID 26013373, PMID 26175027, PMID 26279339, PMID 26291554, PMID 26458804, PMID 26614588, PMID 26639777, PMID 26794905, PMID 26968374, PMID 27102820, PMID 27414655
2014 (5), 2019 (3), 2023 (2), 2018 (1)